Cargando…
Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
BACKGROUND: Type 2 diabetes is frequently seen in patients suffering from obesity. p-synephrine and gliclazide are widely used medicines for the treatment of obesity and diabetes, respectively. OBJECTIVES: The present study was undertaken to determine the potential for interactions between p-synephr...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148059/ https://www.ncbi.nlm.nih.gov/pubmed/29103851 http://dx.doi.org/10.1016/j.jaim.2017.04.010 |